Articles

Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion

Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center Houston, TX, USA
Vol. 99 No. 8 (2014): August, 2014 https://doi.org/10.3324/haematol.2014.104661